In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II StudyJoshua Brody, Ronald Levy, Debra K. Czerwinski et al.|Journal of Clinical Oncology|2010Cited by 487